Increased E2F2 predicts poor prognosis in patients with HCC based on TCGA data

BMC Cancer

Table 1 HCC patient characteristics based on TCGA

Clinical characteristics		Total (424)	%
Age (years)	>40	342	91.0
Age (years)	≤40	34	9.0
Gender	male	255	67.6
Gender	female	122	32.4
BMI	≥25	161	47.2
BMI	<25	180	52.8
Family history of cancer	Yes	114	35.0
Family history of cancer	No	212	65.0
Histologic grade	G1-G2	235	63.1
Histologic grade	G3-G4	137	36.8
Clinical stage	I-II	262	74.2
Clinical stage	III-IV	91	25.8
T	T1-T2	280	74.9
T	T3-T4	94	25.1
N	N0	257	98.5
N	N1	4	1.5
M	M0	272	98.6
M	M1	4	1.4
Residual tumor	R0	330	94.8
Residual tumor	R1	18	5.2
Tumor status	tumor free	236	67.6
Tumor status	with tumor	113	32.4
Vascular invasion	Yes	111	34.6
Vascular invasion	No	210	65.4
Child-pugh	A	223	91.0
Child-pugh	B-C	22	9.0
AFP	AFP<20	152	43.6
	20<AFP < 400	67	19.2
	AFP ≥ 400	130	37.2
New tumor event	Yes	98	36.0
New tumor event	No	174	64.0
History of alcohol consumption	Yes	118	33.0
History of alcohol consumption	No	240	67.0
Postoperative ablation embolization	Yes	28	7.9
Postoperative ablation embolization	No	325	92.1
Radiation therapy	Yes	8	2.3
Radiation therapy	No	344	97.7

T = topography distribution; N = lymph node metastasis; M = distant metastasis; AFP Alpha fetal protein

ISSN: 1471-2407